Formycon Chief Sees COVID-19 Boosting Biosimilars

As Firm Offers Pipeline Update Amid Coronavirus Pandemic

 
• By David Wallace
  
Question_Blocks
At least one of Formycon’s biosimilar projects remains a mystery • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products